ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
129.110,38
-0,16%
S&P 500
5.667,20
0,64%
US Dollar vs BRL
5,4292
-0,35%
Bitcoin
64.742,21
-0,17%
Brent Oil
83,325
-1,20%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Allos Therapeutics, Inc. (MM) (ALTH)

  7. Allos Therapeutics, Inc. (MM) (ALTH) Notícias

ALTH

Allos Therapeutics, Inc. (MM) (ALTH)

Allos Therapeutics, Inc. (MM)
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:ALTH
DataHoraFonteTítuloCódigoCompanhia
04/02/200818:23Edgar (US Regulatory)Allos Therapeutics Inc - Initial Statement of Beneficial Ownership (3)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
29/01/200811:00PR Newswire (US)Allos Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device ConferenceNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
28/01/200811:00PR Newswire (US)Allos Therapeutics Appoints Bruce K. Bennett as Vice President, ManufacturingNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
17/01/200820:00Edgar (US Regulatory)Allos Therapeutics Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
07/01/200819:47Edgar (US Regulatory)Allos Therapeutics Inc - Current report filing (8-K)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
07/01/200811:00PR Newswire (US)Allos Therapeutics Initiates Phase 2b Study of PDX in Patients With Non-small Cell Lung CancerNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
27/12/200711:00PR Newswire (US)Interim Safety Analysis Supports Continuation of Allos Therapeutics' Pivotal Phase 2 PROPEL Trial of PDX in Patients with PeriphNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
11/12/200711:00PR Newswire (US)Allos Therapeutics to Present at the 2008 JPMorgan Healthcare ConferenceNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
05/12/200711:00PR Newswire (US)Allos Therapeutics to Present at the 2007 RBC Capital Markets Healthcare ConferenceNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
29/11/200711:00PR Newswire (US)Allos Therapeutics to Present at the 2007 BMO Capital Markets Focus on Healthcare ConferenceNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
20/11/200711:00PR Newswire (US)Allos Therapeutics to Present at the 2007 Lazard Capital Markets Healthcare Investor ConferenceNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
12/11/200719:00PR Newswire (US)Allos Therapeutics Initiates Study of RH1 in Patients with Advanced Solid Tumors or non-Hodgkin's LymphomaNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
07/11/200719:00PR Newswire (US)Allos Therapeutics to Present at the 2007 JMP Securities Healthcare Focus ConferenceNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
05/11/200717:02Edgar (US Regulatory)Allos Therapeutics Inc - Quarterly Report (10-Q)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
05/11/200710:30PR Newswire (US)Allos Therapeutics Reports Third Quarter 2007 Financial ResultsNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
31/10/200710:00PR Newswire (US)Allos Therapeutics to Present at the 2007 Acumen BioFin Rodman & Renshaw ConferenceNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
25/10/200718:01PR Newswire (US)Three PDX (Pralatrexate) Studies Presented at the 2007 AACR-NCI-EORTC ConferenceNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
16/10/200709:55PR Newswire (US)Allos Therapeutics to Report 2007 Third Quarter Financial Results on November 5, 2007NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
26/09/200711:43Edgar (US Regulatory)Allos Therapeutics Inc (Other) (SC 13G)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
24/09/200716:35Edgar (US Regulatory)Allos Therapeutics Inc (Other) (8-K)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
24/09/200708:30PR Newswire (US)Interim Response and Safety Analyses Support Continuation of Allos Therapeutics' Pivotal Phase 2 PROPEL Trial of PDX in PatientsNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
13/09/200709:00PR Newswire (US)Allos Therapeutics to Present at the 2007 UBS Global Life Sciences ConferenceNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
04/09/200709:00PR Newswire (US)Allos Therapeutics to Present at the Bear Stearns 20th Annual Healthcare ConferenceNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
15/08/200709:00PR Newswire (US)Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell LymphomaNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
07/08/200710:00PR Newswire (US)Allos Therapeutics Reports Second Quarter 2007 Financial ResultsNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
18/07/200709:00PR Newswire (US)Allos Therapeutics to Report 2007 Second Quarter Financial Results on August 7, 2007NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
25/06/200710:30PR Newswire (US)Allos Therapeutics Selected to Join Russel 3000 IndexNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
19/06/200707:30PR Newswire (US)Allos Therapeutics Reports Results for Phase 3 Enrich Study of Efaproxyn in Women With Brain Metastases Originating From BreastNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
31/05/200718:01PR Newswire (US)Allos Therapeutics Initiates Phase I/II Study of PDX and Gemcitabine in Patients With Non-Hodgkin's Lymphoma or Hodgkin's DiseasNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
23/05/200718:55PR Newswire (US)Allos Therapeutics Files Shelf Registration StatementNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
 Apresentando as notícias mais relevantes sobre:NASDAQ:ALTH

Seu Histórico Recente

BOV
HAGA3
HAGA ON
BOV
IBOV
Índice Bovespa
BOV
TELB4
TELEBRAS PN
BOV
AZEV4
AZEVEDO PN
BOV
GFSA3
GAFISA ON
BOV
AMER3
Americanas ON
BOV
PCAR3
PÃO DE AÇUCAR ON
BOV
NGRD3
Neogrid Participacoes ON
BOV
COGN3
COGNA ON
BOV
MGLU3
MAGAZINE LUIZA ON
BOV
VVEO3
CM Hospitalar ON
BOV
JFEN3
JOAO FORTES ON
BOV
AMAR3
LOJAS MARISA ON
BOV
HBOR3
HELBOR ON
BOV
GOLL4
GOL PN
BOV
BOBR4
BOMBRIL PN
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados